Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
221 CHF | +1.01% | -0.50% | -9.61% |
26/04 | Roche: positive CHMP opinion for Alecensa | CF |
26/04 | Roche’s Lung Cancer Drug Alecensa Backed for Approval in EU | MT |
Sales 2024 * | 60.04B 65.65B 5,481B | Sales 2025 * | 63.83B 69.8B 5,828B | Capitalization | 178B 195B 16,270B |
---|---|---|---|---|---|
Net income 2024 * | 13.31B 14.56B 1,215B | Net income 2025 * | 14.75B 16.13B 1,347B | EV / Sales 2024 * | 3.21 x |
Net Debt 2024 * | 14.24B 15.57B 1,300B | Net Debt 2025 * | 8.17B 8.93B 746B | EV / Sales 2025 * | 2.92 x |
P/E ratio 2024 * |
13
x | P/E ratio 2025 * |
11.8
x | Employees | 1,03,605 |
Yield 2024 * |
4.4% | Yield 2025 * |
4.55% | Free-Float | 88.91% |
Latest transcript on Roche Holding AG
1 day | +1.01% | ||
1 week | -0.50% | ||
Current month | -3.79% | ||
1 month | -2.73% | ||
3 months | -10.69% | ||
6 months | -6.85% | ||
Current year | -9.61% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 01/03/01 | |
Severin Schwan
CHM | Chairman | 57 | 01/08/01 |
Alan Hippe
DFI | Director of Finance/CFO | 57 | 01/11/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bernard Poussot
BRD | Director/Board Member | 72 | 03/15/03 |
Director/Board Member | 59 | - | |
Director/Board Member | 65 | 01/96/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
9.03% | 121 M€ | -.--% | - | |
8.46% | 18 M€ | +3.79% | - | |
4.67% | 2 M€ | -.--% | ||
2.85% | 6 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 221 | +1.01% | 1,087,703 |
25/24/25 | 218.8 | -1.53% | 1,598,654 |
24/24/24 | 222.2 | -3.27% | 2,211,530 |
23/24/23 | 229.7 | +1.73% | 2,208,142 |
22/24/22 | 225.8 | +1.67% | 1,837,156 |
Delayed Quote Swiss Exchange, April 26, 2024 at 09:01 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.61% | 193B | |
+25.83% | 653B | |
+27.00% | 556B | |
-6.76% | 354B | |
+20.34% | 331B | |
+3.00% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-6.26% | 144B | |
-11.77% | 143B |
- Stock Market
- Equities
- ROG Stock